Ignite Creation Date:
2025-12-24 @ 12:19 PM
Ignite Modification Date:
2026-01-19 @ 5:48 AM
Study NCT ID:
NCT02688361
Status:
COMPLETED
Last Update Posted:
2019-01-24
First Post:
2016-02-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2016-04-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-13
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-18
First Submit QC Date:
None
Study First Post Date:
2016-02-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-23
Last Update Post Date:
2019-01-24
Last Update Post Date Type:
ACTUAL